OptumHealth Education |

Create an account here to begin participating in activities and to claim your credit.

32nd Annual National Conference
October 2–4, 2023, Minneapolis, MN

A Black man with tan pants and a grey shirt sits opposite a Black man in black pants, a white collared shirt and a grey sweater holding an ipad Beginning June 27, 2023, all DEA-registered and new medical practitioners are required to attest to completion of 8-hours of training on the treatment and management of patients with opioid or other substance use disorders. To help practitioners meet this requirement, we would like to highlight the activity, Current Opioid Prescribing Guidelines: Ensuring Safe and Effective Pain Management, as well as other activities related to substance use disorder.

Title
A Closer Look at Novel Treatment Therapies for Acute Myeloid Leukemia
A Firm Foundation: Partnerships in Child Welfare & Juvenile Justice
A Model for Transplant Programs: Improving Access to Care
Achieving Value-Based Care: The Role of Oncology Clinical Pathways
Across the Sexual Orientation and Gender Identity Spectrum: A Call to Action
Active Surveillance and Management of Prostate Cancer
Addressing the Unpredictable Diagnostic Odyssey of Rare Disease
Advance Your Skills in Supporting the Family Caregiver
Advanced Degenerative Joint Disease and Chronic Lower Back Pain: Evidence-Based Approaches to Care
Advances in Gene Therapy for Sickle Cell Disease and Thalassemia
Advancing Complex Care Philosophy: Tools for Healing-Centered Care
Ambulatory Allogeneic Transplant: Strategies for a Safe and Optimal Process
Artificial Intelligence in Health Care
As Science Moves to Genetic Testing and Treatment: Part 2, Genetic-Informed Treatments
Behavioral Health Identification, Treatment and Referral in Primary Care-Part One: Depression and Follow-up After Higher Levels of Care

OptumHealth Education